Cargando…
Characterisation of CorGlaes(®) Pure 107 fibres for biomedical applications
A degradable ultraphosphate (55 mol % P(2)O(5)) quinternary phosphate glass composition has been characterised in terms of its chemical, mechanical and degradation properties both as a bulk material and after drawing into fibres. This glass formulation displayed a large processing window simplifying...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007269/ https://www.ncbi.nlm.nih.gov/pubmed/27582069 http://dx.doi.org/10.1007/s10856-016-5752-z |
_version_ | 1782451176904589312 |
---|---|
author | Colquhoun, Ross Gadegaard, Nikolaj Healy, David M. Tanner, K. Elizabeth |
author_facet | Colquhoun, Ross Gadegaard, Nikolaj Healy, David M. Tanner, K. Elizabeth |
author_sort | Colquhoun, Ross |
collection | PubMed |
description | A degradable ultraphosphate (55 mol % P(2)O(5)) quinternary phosphate glass composition has been characterised in terms of its chemical, mechanical and degradation properties both as a bulk material and after drawing into fibres. This glass formulation displayed a large processing window simplifying fibre drawing. The fibres displayed stiffness and strength of 65.5 ± 20.8 GPa and 426±143 MPa. While amorphous discs of the glass displayed a linear dissolution rate of 0.004 mg cm(−2) h(−1) at 37 °C, in a static solution with a reduction in media pH. Once drawn into fibres, the dissolution process dropped the pH to <2 in distilled water, phosphate buffer saline and corrected-simulated body fluid, displaying an autocatalytic effect with >90 % mass loss in 4 days, about seven times faster than anticipated for this solution rate. Only cell culture media was able to buffer the pH taking over a week for full fibre dissolution, however, still four times faster dissolution rate than as a bulk material. However, at early times the development of a HCA layer was seen indicating potential bioactivity. Thus, although initial analysis indicated potential orthopaedic implant applications, autocatalysis leads to accelerating degradation in vitro. |
format | Online Article Text |
id | pubmed-5007269 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-50072692016-09-16 Characterisation of CorGlaes(®) Pure 107 fibres for biomedical applications Colquhoun, Ross Gadegaard, Nikolaj Healy, David M. Tanner, K. Elizabeth J Mater Sci Mater Med Clinical Applications of Biomaterials A degradable ultraphosphate (55 mol % P(2)O(5)) quinternary phosphate glass composition has been characterised in terms of its chemical, mechanical and degradation properties both as a bulk material and after drawing into fibres. This glass formulation displayed a large processing window simplifying fibre drawing. The fibres displayed stiffness and strength of 65.5 ± 20.8 GPa and 426±143 MPa. While amorphous discs of the glass displayed a linear dissolution rate of 0.004 mg cm(−2) h(−1) at 37 °C, in a static solution with a reduction in media pH. Once drawn into fibres, the dissolution process dropped the pH to <2 in distilled water, phosphate buffer saline and corrected-simulated body fluid, displaying an autocatalytic effect with >90 % mass loss in 4 days, about seven times faster than anticipated for this solution rate. Only cell culture media was able to buffer the pH taking over a week for full fibre dissolution, however, still four times faster dissolution rate than as a bulk material. However, at early times the development of a HCA layer was seen indicating potential bioactivity. Thus, although initial analysis indicated potential orthopaedic implant applications, autocatalysis leads to accelerating degradation in vitro. Springer US 2016-08-31 2016 /pmc/articles/PMC5007269/ /pubmed/27582069 http://dx.doi.org/10.1007/s10856-016-5752-z Text en © The Author(s) 2016 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Clinical Applications of Biomaterials Colquhoun, Ross Gadegaard, Nikolaj Healy, David M. Tanner, K. Elizabeth Characterisation of CorGlaes(®) Pure 107 fibres for biomedical applications |
title | Characterisation of CorGlaes(®) Pure 107 fibres for biomedical applications |
title_full | Characterisation of CorGlaes(®) Pure 107 fibres for biomedical applications |
title_fullStr | Characterisation of CorGlaes(®) Pure 107 fibres for biomedical applications |
title_full_unstemmed | Characterisation of CorGlaes(®) Pure 107 fibres for biomedical applications |
title_short | Characterisation of CorGlaes(®) Pure 107 fibres for biomedical applications |
title_sort | characterisation of corglaes(®) pure 107 fibres for biomedical applications |
topic | Clinical Applications of Biomaterials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007269/ https://www.ncbi.nlm.nih.gov/pubmed/27582069 http://dx.doi.org/10.1007/s10856-016-5752-z |
work_keys_str_mv | AT colquhounross characterisationofcorglaespure107fibresforbiomedicalapplications AT gadegaardnikolaj characterisationofcorglaespure107fibresforbiomedicalapplications AT healydavidm characterisationofcorglaespure107fibresforbiomedicalapplications AT tannerkelizabeth characterisationofcorglaespure107fibresforbiomedicalapplications |